Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer
Other Articles
A dynamic view of chemotherapy effectiveness
August 12, 2019
Tumour lineage shapes BRCA-mediated phenotypes
July 27, 2019